Who Will Emerge As Best In Class Of The FGF21 Analogs In NASH?

 
• By Joseph Haas
  
2023 AASLD
Three firms developing FGF21 analogs for NASH made their cases at AASLD • Source: Scrip
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business